Foresight Diagnostics Announces $58.75 Million Series B Financing Led By Foresite Capital To Commercialize Ultrasensitive Liquid Biopsy Mrd Testing Platform
Amount Raised
$58.8 Million
Round Type
Series B
BoulderBiotechnologyHealth CareInvestors
Description
Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced today that it has closed an oversubscribed Series B financing round of $58.75 million. The financing was led by Foresite Capital, with participation by Civilization Ventures, Bluebird Ventures, Pear Ventures, Agent Capital, Stanford University, and The University of Colorado Healthcare Innovation Fund. The proceeds will be used to accelerate the clinical development and commercialization of Foresight Diagnostics' cancer recurrence testing platform, PhasED-SeqTM.
Quick answer
Foresight Diagnostics raised $58.8 Million in a Series B round, dated April 27, 2023. Investors: Pear VC, University Of Colorado Healthcare Innovation Fund, Stanford University, Agent Capital, Bluebird Ventures, Civilization Ventures and Foresite Capital. Foresight Diagnostics is based in Boulder, Colorado, United States.
- How much did Foresight Diagnostics raise?
- Foresight Diagnostics raised $58.8 Million in a Series B round on April 27, 2023.
- Who invested in Foresight Diagnostics?
- Pear VC, University Of Colorado Healthcare Innovation Fund, Stanford University, Agent Capital, Bluebird Ventures, Civilization Ventures and Foresite Capital are named as investors in this round.
- What does Foresight Diagnostics do?
- Foresight Diagnostics is a privately held cancer diagnostics company and CLIA-registered laboratory.
- Where is Foresight Diagnostics based and how big is it?
- Foresight Diagnostics is based in Boulder, Colorado, United States. Fundz records about 136 employees.
- Who are the decision-makers at Foresight Diagnostics?
- Fundz holds 1 contact at Foresight Diagnostics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Foresight Diagnostics that raised within 45 days of this round, from Fundz verified event records.
- Avenda Health, Inc. raised $3.5M (Series B) on June 8, 2023.
- Kate Therapeutics raised $51M (Series A) on June 8, 2023.
- Upstream Bio raised $200M (Series B) on June 8, 2023.
- VERTOS MEDICAL INC raised $26M (Funding Round) on June 7, 2023.
- Bitterroot Bio raised $145M (Series A) on June 7, 2023.
- Candesant Biomedical, Inc. raised $35M (Series B) on June 6, 2023.
Who to call at Foresight Diagnostics, and when
A new round usually means Foresight Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Foresight Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Foresight Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Foresight Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Foresight Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansForesight Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.